Deborah Huebbe Youhn, MD
Dermatology · Iowa City, IANPI 1063448553
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.0% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 36.2% of the total. Reporting peaked in 2019 at $535 and has fallen 96.9% since, to $16 in 2025.
Across 100 payments — averaging $18.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$663
- Novartis$295
- Sun Pharmaceutical Industries Inc.$146
- Galderma Laboratories, L.p.$141
- LEO Pharma Inc.$126
- Almirall LLC$110
- plus $349 from 7 others
What the payments were for
- Food & beverage$1,71994%
- Education$1106%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $663 |
| Novartis | 14 | $295 |
| Sun Pharmaceutical Industries Inc. | 3 | $146 |
| Galderma Laboratories, L.p. | 10 | $141 |
| LEO Pharma Inc. | 8 | $126 |
| Almirall LLC | 2 | $110 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $82 |
| Pfizer | 6 | $82 |
| Johnson & Johnson | 3 | $61 |
| Sanofi | 3 | $61 |
| Mayne Pharma Commercial LLC | 2 | $27 |
| Nabriva Therapeutics, PLC | 1 | $23 |
| Aclaris Therapeutics, Inc. | 1 | $13 |
How this compares
$1,829 in reported general payments places this provider in the 65th percentile of 92 dermatology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 20 | $1,442 |
| Clobetasol Propionate | 20 | $1,346 |
| CiclopiroxCiclopirox Olamine | 32 | $726 |
| Ketoconazole | 35 | $674 |
| Triamcinolone Acetonide | 60 | $462 |
| Mupirocin | 40 | $243 |
| Hydrocortisone | 21 | $66 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Iowa City
- Ali JabbariIowa City$38K
- Janet FairleyIowa City$4K
- Kevin CheungIowa City$2K
- Sarah MinionIowa City$838
- Heather CilibertoIowa City$789
- Roshan AbidIowa City$716
- Laura Correa FerrerIowa City$555
- Carmine PalladinoIowa City$546
- Samuel PalmerIowa City$499
- Zakariyah Sharif-SidiIowa City$410
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.